Celldex Therapeutics CLDX
NASDAQ CLDX
$29.25 +0.28 (+0.97%)
At close: Oct 23, 2026 · 4:00 PM EDT

Celldex Therapeutics (CLDX) Sale and Maturity of Investments (2010 - 2026)

Updated

Analysis

Celldex Therapeutics (CLDX) Sale and Maturity of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Celldex Therapeutics 2.30 Bn 25.29 Mn - 150.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150.51 Mn
Mar 31, 2026 133.37 Mn
Dec 31, 2025 111.50 Mn
Sep 30, 2025 116.92 Mn
Jun 30, 2025 172.84 Mn
Mar 31, 2025 195.04 Mn
Dec 31, 2024 153.98 Mn
Sep 30, 2024 148.36 Mn
Jun 30, 2024 122.06 Mn
Mar 31, 2024 77.31 Mn
Dec 31, 2023 70.89 Mn
Sep 30, 2023 39.55 Mn
Jun 30, 2023 83.15 Mn
Mar 31, 2023 127.00 Mn
Dec 31, 2022 87.80 Mn
Sep 30, 2022 86.11 Mn
Jun 30, 2022 78.91 Mn
Mar 31, 2022 27.85 Mn
Dec 31, 2021 45.95 Mn
Sep 30, 2021 13.00 Mn
API Access

Celldex Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=CLDX&period=max&api_key=YOUR_API_KEY